UNITAID selects NGO alternate board member
This article was originally published in Scrip
Dr Tido von Schoen-Angerer, executive director of the Campaign for Access to Essential Medicines of Médecins Sans Frontières, has been selected as a UNITAID alternate board member for NGOs. Dr von Schoen-Angerer joins the board as Dr Mohga Kamal-Yanni, Oxfam's senior policy advisor, steps down. She will continue to be an advisor to the NGO delegation.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.